Can Atalay
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 11
- Oncology 10
- Drug Transport and Resistance Mechanisms 4
- Cancer Risks and Factors 2
- Colorectal Cancer Surgical Treatments 2
- Co-authors
- Kerim Bora Yılmaz (13 shared papers)Ufuk Gündüz (4 shared papers)Lütfi Doğan (15 shared papers)Cihangir Özaslan (16 shared papers)Çiğdem Irkkan (4 shared papers)Özlem Darcansoy İşeri (1 shared paper)Meltem Demirel Kars (1 shared paper)Fikret Arpacı (1 shared paper)
- Journals
- Surgery Today (4 papers)Annals of Surgical Oncology (1 paper)Journal of Chemotherapy (1 paper)Advances in Therapy (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- TürkiyeUnited States
In The Last Decade
Can Atalay
54 papers receiving 873 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 248
- Oncology 127
- Pathology and Forensic Medicine 53
- Rehabilitation 16
- Surgery 91
Countries citing papers authored by Can Atalay
This map shows the geographic impact of Can Atalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Atalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Atalay more than expected).
Fields of papers citing papers by Can Atalay
This network shows the impact of papers produced by Can Atalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Atalay. The network helps show where Can Atalay may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Atalay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 239 | |
| 2 | 2010 | 105 | |
| 3 | 2003 | 34 | |
| 4 | 2008 | 33 | |
| 5 | 2009 | 33 | |
| 6 | The role of anti-CENP-B and anti-SS-B antibodies in breast cancer. | 2005 | 26 |
| 7 | 2006 | 25 | |
| 8 | 2011 | 24 | |
| 9 | 2012 | 23 | |
| 10 | 2005 | 20 | |
| 11 | 2008 | 20 | |
| 12 | 2010 | 20 | |
| 13 | Prognostic factors affecting survival in male breast cancer. | 2003 | 19 |
| 14 | Epigenetics in breast cancer. | 2013 | 18 |
| 15 | 2005 | 17 | |
| 16 | 2014 | 17 | |
| 17 | Menstrual cycle and hormone receptor status in breast cancer patients. | 2002 | 16 |
| 18 | 2009 | 16 | |
| 19 | 2013 | 14 | |
| 20 | 2010 | 12 |
About Can Atalay
Can Atalay is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 56 papers that have together received 913 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Pleural and Pulmonary Diseases (3 papers), Cancer Risks and Factors (2 papers), Breast Implant and Reconstruction (2 papers) and Colorectal Cancer Surgical Treatments (2 papers). The work is most often cited by research in Cancer Research (248 citations), Oncology (127 citations), Pathology and Forensic Medicine (53 citations), Rehabilitation (16 citations) and Surgery (91 citations). Can Atalay has collaborated with scholars based in Türkiye and United States. Frequent co-authors include Kerim Bora Yılmaz, Ufuk Gündüz, Lütfi Doğan, Cihangir Özaslan, Çiğdem Irkkan, Özlem Darcansoy İşeri, Meltem Demirel Kars, Fikret Arpacı, Bahadır Çetin and Niyazi Karaman. Their work appears in journals such as Surgery Today, Annals of Surgical Oncology, Journal of Chemotherapy, Advances in Therapy and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.